The impact of oral diseases in cirrhosis on complications and mortality [0.03%]
肝硬化患者口腔疾病对并发症和死亡率的影响
Lea Ladegaard Grønkjær,Palle Holmstrup,Peter Jepsen et al.
Lea Ladegaard Grønkjær et al.
Background and aim: The aims of this study were to describe the prevalence of various oral diseases and to examine the association of the oral diseases with complications and mortality of cirrhosis. ...
Accuracy of noninvasive tests in the prediction of portal hypertensive gastropathy in Egyptian patients with cirrhosis [0.03%]
无创检测预测埃及肝硬化患者门脉高压性胃病准确性的研究
Ibrahim F Amer,Eslam M El Shennawy,Hassan El Batea et al.
Ibrahim F Amer et al.
Background and aim: Liver cirrhosis (LC) is commonly associated with portal hypertensive gastropathy (PHG), and it causes gastrointestinal (GI) bleeding. Esophagogastroduodenoscopy (EGD) is the gold standard in diagnosing...
Predictive value of risk score using Kyoto classification of gastritis a few years prior to diagnosis of early gastric cancer [0.03%]
京都分类胃炎风险评分在早期胃癌诊断前若干年的预测价值
Yo Fujimoto,Yasumi Katayama,Yoshinori Gyotoku et al.
Yo Fujimoto et al.
Background and aim: Based on past diagnostic classifications of gastritis, the Kyoto classification of gastritis adopts simpler, more objective gastritis findings according to Helicobacter pylori infection status and eval...
Propofol versus midazolam for sedation during radiofrequency ablation in patients with hepatocellular carcinoma [0.03%]
用于肝细胞癌射频消融镇静的丙泊酚与咪达唑仑的比较研究
Naoya Kanogawa,Sadahisa Ogasawara,Yoshihiko Ooka et al.
Naoya Kanogawa et al.
Background and aim: Standardization of the sedation protocol during radiofrequency ablation (RFA) in patients with hepatocellular carcinoma (HCC) is needed. This randomized, single-blind, investigator-initiated trial comp...
Conventional peritoneal cytology lacks the prognostic significance of detecting local or peritoneal recurrence in colorectal cancer: An Egyptian experience [0.03%]
常规腹膜细胞学缺乏检测结直肠癌局部或腹膜复发的预后意义：一项埃及经验
Mohamed Shalaby,Tarek S El Baradie,Mohamed Salama et al.
Mohamed Shalaby et al.
Background and aim: Colorectal cancer (CRC) accounts for over 8% of all deaths each year, with 1.2 million new cases diagnosed annually worldwide. It represents the seventh most common cancer in Egypt. Early detection of ...
Bone and renal safety profile at 72 weeks after switching to tenofovir alafenamide in chronic hepatitis B patients [0.03%]
慢性乙型肝炎患者切换至泰诺福韦艾拉酚胺后72周时的骨骼和肾脏安全性特征分析
Brian T Lee,Mimi Chang,Carolina Lim et al.
Brian T Lee et al.
Background and aim: Tenofovir disoproxil fumarate (TDF) has been efficacious in treating chronic hepatitis B (CHB), but long-term use is accompanied by a decline in renal function and bone mineral density (BMD). Tenofovir...
Hepatitis C direct-acting antiviral outcomes in patients 75 years and older [0.03%]
75岁及以上患者的丙型肝炎直接抗病毒药物疗效
Parmvir Parmar,Stephen D Shafran,Sergio M Borgia et al.
Parmvir Parmar et al.
Background and aim: Elderly patients with hepatitis C virus (HCV) infection have worse interferon-based treatment outcomes than young patients. Direct-acting antiviral (DAA) regimens have enabled the treatment of previous...
Gastric xanthoma is correlated with early gastric cancer of previously Helicobacter pylori-infected gastric mucosa [0.03%]
胃黏膜类杆杆菌感染以前的胃肠道黄色瘤与早期胃癌有关
Narihiro Shibukawa,Shohei Ouchi,Shuji Wakamatsu et al.
Narihiro Shibukawa et al.
Background and aim: Successful Helicobacter pylori eradication has been shown to prevent the development of gastric cancer (GC), but clinical evidence for factors that correlate with GC of previously H. pylori-infected ga...
Effectiveness of educational intervention carried out by clinical pharmacists for the quality of life of patients with irritable bowel syndrome: A randomized controlled trial [0.03%]
临床药师开展教育干预改善肠易激患者生活质量的疗效研究——随机对照试验
Vo Duy Thong,Nguyen Ngoc Phuc,Bui Thi Huong Quynh
Vo Duy Thong
Background and aim: Irritable bowel syndrome (IBS) is associated with repetitive gastrointestinal symptoms that greatly reduce the patient's quality of life (QoL). Training regarding IBS-related knowledge, medication adhe...
Long-term outcomes of perianal fistulizing Crohn's disease in the biologic era [0.03%]
生物制剂时代肛周瘘管性克罗恩病的长期结局
Tanya Lee,Michael A Kamm,Sally Bell et al.
Tanya Lee et al.
Background and aim: While the advent of biologic therapy has led to improved outcomes in perianal fistulizing Crohn's disease (pfCD), loss of response is common. Previous studies suggest that patients who achieve radiolog...